US Stock MarketDetailed Quotes

SKYE BIOSCIENCE INC (SKYE)

Watchlist
  • 0.5410
  • -0.0079-1.44%
Close Aug 13 16:00 ET
  • 0.5320
  • -0.0090-1.66%
Post 19:34 ET
19.01MMarket Cap-0.37P/E (TTM)

About SKYE BIOSCIENCE INC Company

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

Company Profile

SymbolSKYE
Company NameSKYE BIOSCIENCE INC
Listing DateApr 11, 2024
Issue Price0.05
ISINUS83086J2006
Founded2011
CEOMr. Punit Dhillon
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address11250 El Camino Real,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-410-0266

Company Executives

  • Name
  • Position
  • Salary
  • Punit Dhillon
  • Director, Principal Accounting Officer, President and Chief Executive Officer
  • 1.36M
  • John P. Sharp
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Tuan Tu Diep
  • Chief Operating Officer
  • 875.94K
  • Chris Twitty, PhD
  • Chief Scientific Officer
  • --
  • Paul Grayson
  • Chairman of the Board
  • 369.36K
  • Dr. Andrew J. Schwab, PhD
  • Director
  • 109.44K
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Independent Director
  • 131.94K
  • Dr. Deborah Charych
  • Independent Director
  • 116.94K
  • Dr. Annalisa Mary Jenkins, F.R.C.P.,M.B.B.S.
  • Independent Director
  • 133.82K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More